Orgenesis to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference
GERMANTOWN, Md., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a leading cell and gene therapy enabling company providing centralized CDMO manufacturing and development services through its subsidiary …